The latest news from Corcept Therapeutics on their Phase 3 GRACE clinical trial clinical trial is excellent. The drug relacorilant significantly reduced high blood pressure and blood sugar levels in people with endogenous Cushing’s syndrome.
Cushing’s
Cushing’s syndrome is a disorder that occurs when your body makes too much of the hormone cortisol over a long period of time. Cortisol is sometimes called the “stress hormone” because it helps your body respond to stress.
Dr. Blevins discusses the drug Pasireotide
In this podcast, Dr. Blevins gives us an overview of the drug Pasireotide for Cushing’s. Photo by: JD Faccinetti (close up at the California Redwoods forest) Music by: Bad at Math
Symptoms and signs of Cushing’s syndrome
This podcast is brought to you in part by a generous contribution from Corcept Therapeutics. From Lewis S Blevins Jr. MD – There is a wide spectrum of clinical presentations of patients with hypercortisolism, and in
Making a difference
Today we begin a new series of feature articles that highlight the tireless work that people do to help others. Here are three amazing human beings: Jill Sisco runs the Acromegaly Community website and
Podcasts series on recurring Cushing’s disease
Pituitary World News podcast series on recurring Cushing’s disease is made possible in part by a generous grant from Corcept Therapeutics This series covers the approaches, debates, evaluations, and the difficulties in diagnosis and managing
Cushing’s part 4: musings
This is the 4th podcast in our series on residual or recurring Cushing’s disease. In part 4, Dr. Blevins shares additional information to empower patients to work with their physicians more effectively. “Music: http://www.bensound.com/royalty-free-music
Podcast. Part 3: Cushing’s medical management
This is part 3 in our series of podcasts on residual or recurring Cushing’s disease. Part 3 focuses on the medical management of Cushing’s and on the drug Korlym (mifepristone).
Recurring Cushing’s disease series: Part 2 management
From Lewis S. Blevins Jr, MD – In Part Two of this series, Dr. Blevins discusses approaches to the management of residual and recurring Cushing’s disease. “Music: http://www.bensound.com/royalty-free-music
Recurring Cushing’s disease podcast series: Part 1 approaches and challenges
From Lewis S. Blevins Jr, MD – In Part One of this series, Dr. Blevins focuses on the challenges of identifying patients with residual or recurring Cushing’s disease after pituitary surgery, the different approaches, debates,
Aggressive Pituitary Tumors
In this podcast Dr. Blevins discusses aggressive pituitary tumors. Learn what defines a pituitary malignancy and the differences between benign and malignant tumors. What is an aggressive tumor and what makes it behave that way.
Cushing’s disease and IPSS.
From Lewis S Blevins, Jr. MD – Ninety per-cent of ACTH-dependent causes of hypercortisolism are related to pituitary adenoma. The remaining 10% are related to ectopic, or non pituitary, sources of ACTH secretion. One-third of
Reporting from the 2015 Pituitary Disorders, Advances in Diagnosis and Management conference at UCSF
In this podcast, Dr. Lewis Blevins and Jorge Faccinetti discuss the highlights of the conference held in San Francisco in late October. The program focused on the latest updates and recent advances regarding pituitary tumors
Evaluation of the use of the Late Night Salivary Cortisol (LNSC) test
From Lewis S Blevins, Jr. MD – Researchers at Harvard Medical School have reported their results on the evaluation of the use of the Late Night Salivary Cortisol (LNSC) in the evaluation of patients who